目前，吸入型皮质类固醇（ICS）是治疗哮喘病的常用药，但其剂量如超过1000ndd，可影响骨代谢参数。丙酸氟替卡松（FP）是一种新型、高效的ICS，其抗炎作用比倍氯米松（BDP）强两倍。本研究旨在比较临床相当剂量的FP（750pgld）和BDP（500［吵d）对哮喘患者骨代谢指标及皮质醇 At present, inhaled corticosteroids (ICS) are commonly used drugs for the treatment of asthma, but their doses, such as over 1000d, can affect bone metabolism parameters. Fluticasone propionate (FP) is a new and highly effective ICS with anti-inflammatory effects twice as strong as beclomethasone (BDP). The purpose of this study was to compare the clinically relevant doses of FP (750 pgld) and BDP (500 d) on bone metabolic parameters and cortisol